Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.The Heilongjiang Food and Drug Administration (Heilongjiang FDA) has given production license for 13 medical products to China Sky One Medical and Heilongjiang Traditional Chinese Medical University (HTCMU) in China.
Subscribe to our email newsletter
The products include Kang Xi Eye Patch, KangXi Dental Ulcer Membrane, KangXi Anti-virus Mouthwash, KangXi Dental Ulcer Mouthwash, KangXi Snore Stopper, Kang Xi Periarthritis Shoulder Patch, KangXi Cervical Vertebrae Patch, KangXi Lumbar Patch, KangXi Rheumatoid Patch, KangXi Hyperostosis Patch, BiChang Nose Patch, YuFu Scar Patch and YuFu Wound Healing Patch.
China Sky One Medical is planning to launch these products in the fourth quarter of 2011.
Currently, the company is preparing for trial production and searching for the best production process for these thirteen products.
China Sky One Medical chairman and CEO Yan-Qing Liu said they are pleased to obtain production licenses for these exciting new products, which as a group will contribute materially to China Sky One’s revenue and net income in 2012.
"As these mostly external-use medical products dovetail well with their existing production facilities and sales network, we expect to manufacture and sell them efficiently without much extra effort," Liu said.